Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
07 2020
Historique:
received: 26 11 2019
accepted: 18 03 2020
pubmed: 21 4 2020
medline: 28 4 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

Missing heritability in human diseases represents a major challenge, and this is particularly true for ABCA4-associated Stargardt disease (STGD1). We aimed to elucidate the genomic and transcriptomic variation in 1054 unsolved STGD and STGD-like probands. Sequencing of the complete 128-kb ABCA4 gene was performed using single-molecule molecular inversion probes (smMIPs), based on a semiautomated and cost-effective method. Structural variants (SVs) were identified using relative read coverage analyses and putative splice defects were studied using in vitro assays. In 448 biallelic probands 14 known and 13 novel deep-intronic variants were found, resulting in pseudoexon (PE) insertions or exon elongations in 105 alleles. Intriguingly, intron 13 variants c.1938-621G>A and c.1938-514G>A resulted in dual PE insertions consisting of the same upstream, but different downstream PEs. The intron 44 variant c.6148-84A>T resulted in two PE insertions and flanking exon deletions. Eleven distinct large deletions were found, two of which contained small inverted segments. Uniparental isodisomy of chromosome 1 was identified in one proband. Deep sequencing of ABCA4 and midigene-based splice assays allowed the identification of SVs and causal deep-intronic variants in 25% of biallelic STGD1 cases, which represents a model study that can be applied to other inherited diseases.

Identifiants

pubmed: 32307445
doi: 10.1038/s41436-020-0787-4
pii: S1098-3600(21)01183-7
doi:

Substances chimiques

ABCA4 protein, human 0
ATP-Binding Cassette Transporters 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1235-1246

Références

Carss KJ, Arno G, Erwood M, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Hum Genet. 2017;100:75–90.
Blacharski PA, Newsome DA. Bilateral macular holes after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol. 1988;105:417–418.
Cornelis SS, Bax NM, Zernant J, et al. In silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases. Hum Mutat. 2017;38:400–408.
Sangermano R, Khan M, Cornelis SS, et al. ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease. Genome Res. 2018;28:100–110.
pubmed: 5749174 pmcid: 5749174
Khan M, Cornelis SS, Khan MI, et al. Cost-effective molecular inversion probe-based ABCA4 sequencing reveals deep-intronic variants in Stargardt disease. Hum Mutat. 2019;40:1749–1759.
Schulz HL, Grassmann F, Kellner U, et al. Mutation spectrum of the ABCA4 gene in 335 Stargardt disease patients from a multicenter German cohort—impact of selected deep intronic variants and common SNPs. Invest Ophthalmol Vis Sci. 2017;58:394–403.
pubmed: 5270621 pmcid: 5270621
Bauwens M, Garanto A, Sangermano R, et al. ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants. Genet Med. 2019;21:1761–1771.
pubmed: 6752479 pmcid: 6752479
Braun TA, Mullins RF, Wagner AH, et al. Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet. 2013;22:5136–5145.
pubmed: 3842174 pmcid: 3842174
Sangermano R, Garanto A, Khan M, et al. Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides. Genet Med. 2019;21:1751–1760.
pubmed: 6752325 pmcid: 6752325
Zernant J, Xie YA, Ayuso C, et al. Analysis of the ABCA4 genomic locus in Stargardt disease. Hum Mol Genet. 2014;23:6797–6806.
pubmed: 4245042 pmcid: 4245042
Bauwens M, De Zaeytijd J, Weisschuh N, et al. An augmented ABCA4 screen targeting noncoding regions reveals a deep intronic founder variant in Belgian Stargardt patients. Hum Mutat. 2015;36:39–42.
Bax NM, Sangermano R, Roosing S, et al. Heterozygous deep-intronic variants and deletions in ABCA4 in persons with retinal dystrophies and one exonic ABCA4 variant. Hum Mutat. 2015;36:43–47.
Fadaie Z, Khan M, Del Pozo-Valero M, et al. Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4. Hum Mutat. 2019;40:2365–2376.
pubmed: 6899986 pmcid: 6899986
Maugeri A, van Driel MA, van de Pol DJR, et al. The 2588G -> C mutation in the ABCR gene is a mild frequent founder mutation in the western European population and allows the classification of ABCR mutations in patients with Stargardt disease. Am J Hum Genet. 1999;64:1024–1035.
pubmed: 1377826 pmcid: 1377826
Rivera A, White K, Stohr H, et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet. 2000;67:800–813.
pubmed: 1287885 pmcid: 1287885
Jaakson K, Zernant J, Kulm M, et al. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum Mutat. 2003;22:395–403.
Maia-Lopes S, Aguirre-Lamban J, Castelo-Branco M, Riveiro-Alvarez R, Ayuso C, Silva ED. ABCA4 mutations in Portuguese Stargardt patients: identification of new mutations and their phenotypic analysis. Mol Vis. 2009;15:584–591.
pubmed: 2660377 pmcid: 2660377
Albert S, Garanto A, Sangermano R, et al. Identification and rescue of splice defects caused by two neighboring deep-intronic ABCA4 mutations underlying Stargardt disease. Am J Hum Genet. 2018;102:517–527.
pubmed: 5985352 pmcid: 5985352
Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc Natl Acad Sci U S A. 2015;112:8415–8420.
pubmed: 4500285 pmcid: 4500285
Allocca M, Doria M, Petrillo M, et al. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest. 2008;118:1955–1964.
pubmed: 2298836 pmcid: 2298836
Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27:2126–2135.
Cremers FPM, Cornelis SS, Runhart EH, Astuti GDN. Author response: penetrance of the ABCA4 p.Asn1868Ile allele in Stargardt disease. Invest Ophthalmol Vis Sci. 2018;59:5566–5568.
Runhart EH, Sangermano R, Cornelis SS, et al. The common ABCA4 variant p.Asn1868Ile shows nonpenetrance and variable expression of Stargardt disease when present in trans with severe variants. Invest Ophthalmol Vis Sci. 2018;59:3220–3231.
Zernant J, Lee W, Collison FT, et al. Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration. J Med Genet. 2017;54:404–412.
pubmed: 5786429 pmcid: 5786429
Hafez M, Hausner G. Convergent evolution of twintron-like configurations: one is never enough. RNA Biol. 2015;12:1275–1288.
pubmed: 4829276 pmcid: 4829276
Zernant J, Lee W, Nagasaki T, et al. Extremely hypomorphic and severe deep intronic variants in the ABCA4 locus result in varying Stargardt disease phenotypes. Cold Spring Harb Mol Case Stud. 2018;4:a002733.
pubmed: 6071568 pmcid: 6071568
Nassisi M, Mohand-Said S, Andrieu C, et al. Prevalence of ABCA4 deep-intronic variants and related phenotype in an unsolved “one-hit” cohort with Stargardt disease. Int J Mol Sci. 2019;20:5053.
pubmed: 6829239 pmcid: 6829239
Runhart EH, Valkenburg D, Cornelis SS, et al. Late-onset Stargardt disease due to mild, deep-intronic ABCA4 alleles. Invest Ophthalmol Vis Sci. 2019;60:4249–4256.
Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211.
pubmed: 3079308 pmcid: 3079308
McVey M, Lee SE. MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings. Trends Genet. 2008;24:529–538.
pubmed: 5303623 pmcid: 5303623
Vissers LE, Bhatt SS, Janssen IM, et al. Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture. Hum Mol Genet. 2009;18:3579–3593.
Bacolla A, Wells RD. Non-B DNA conformations, genomic rearrangements, and human disease. J Biol Chem. 2004;279:47411–47414.
Fingert JH, Eliason DA, Phillips NC, Lotery AJ, Sheffield VC, Stone EM. Case of Stargardt disease caused by uniparental isodisomy. Arch Ophthalmol. 2006;124:744–745.
Riveiro-Alvarez R, Valverde D, Lorda-Sanchez I, et al. Partial paternal uniparental disomy (UPD) of chromosome 1 in a patient with Stargardt disease. Mol Vis. 2007;13:96–101.
pubmed: 2553007 pmcid: 2553007
Liehr T. Cytogenetic contribution to uniparental disomy (UPD). Mol Cytogenet. 2010;3:8.
pubmed: 2853554 pmcid: 2853554
Rivolta C, Berson EL, Dryja TP. Paternal uniparental heterodisomy with partial isodisomy of chromosome 1 in a patient with retinitis pigmentosa without hearing loss and a missense mutation in the Usher syndrome type II gene USH2A. Arch Ophthalmol. 2002;120:1566–1571.
Roosing S, van den Born LI, Hoyng CB, et al. Maternal uniparental isodisomy of chromosome 6 reveals a TULP1 mutation as a novel cause of cone dysfunction. Ophthalmology. 2013;120:1239–1246.
Thompson DA, Gyurus P, Fleischer LL, et al. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2000;41:4293–4299.
Thompson DA, McHenry CL, Li Y, et al. Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively. Am J Hum Genet. 2002;70:224–229.
Wiszniewski W, Lewis RA, Lupski JR. Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14. Hum Genet. 2007;121:433–439.
Souzeau E, Thompson JA, McLaren TL, et al. Maternal uniparental isodisomy of chromosome 6 unmasks a novel variant in TULP1 in a patient with early onset retinal dystrophy. Mol Vis. 2018;24:478–484.
pubmed: 6066270 pmcid: 6066270
Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535–48 e524.

Auteurs

Mubeen Khan (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Stéphanie S Cornelis (SS)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Marta Del Pozo-Valero (MD)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Genetics, IIS-Fundación Jiménez Díaz, CIBERER, Madrid, Spain.

Laura Whelan (L)

The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Ireland.

Esmee H Runhart (EH)

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.

Ketan Mishra (K)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Femke Bults (F)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Yahya AlSwaiti (Y)

St John of Jerusalem Eye Hospital Group, East Jerusalem, Palestine.

Alaa AlTalbishi (A)

St John of Jerusalem Eye Hospital Group, East Jerusalem, Palestine.

Elfride De Baere (E)

Center for Medical Genetics Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.

Sandro Banfi (S)

Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples and Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.

Eyal Banin (E)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Miriam Bauwens (M)

Center for Medical Genetics Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.

Tamar Ben-Yosef (T)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Camiel J F Boon (CJF)

Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Ophthalmology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

L Ingeborgh van den Born (LI)

The Rotterdam Eye Hospital, Rotterdam, The Netherlands.
The Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands.

Sabine Defoort (S)

Service d'exploration de la vision et neuro-ophtalmologie, Centre Hospitalier Universitaire de Lille, Lille, France.

Aurore Devos (A)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Adrian Dockery (A)

The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Ireland.

Lubica Dudakova (L)

Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Ana Fakin (A)

Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.

G Jane Farrar (GJ)

The School of Genetics & Microbiology, Trinity College Dublin, Dublin, Ireland.

Juliana Maria Ferraz Sallum (JMF)

Department of Ophthalmology and Visual Sciences, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Instituto de Genética Ocular, São Paulo, SP, Brazil.

Kaoru Fujinami (K)

UCL Institute of Ophthalmology, London, UK.
Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Graduate School of Health Management, Keio University, Tokyo, Japan.
Moorfields Eye Hospital, London, UK.

Christian Gilissen (C)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Damjan Glavač (D)

Department of Molecular Genetics, Institute of Pathology, University of Ljubljana, Ljubljana, Slovenia.

Michael B Gorin (MB)

Department of Ophthalmology, David Geffen School of Medicine, Stein Eye Institute, University of California-Los Angeles, Los Angeles, CA, USA.
Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.

Jacquie Greenberg (J)

University of Cape Town/MRC Genomic and Precision Medicine Research Unit, Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Takaaki Hayashi (T)

Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.

Ymkje M Hettinga (YM)

Bartiméus Diagnostic Center for Complex Visual Disorders, Zeist, The Netherlands.

Alexander Hoischen (A)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Carel B Hoyng (CB)

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.

Karsten Hufendiek (K)

University Eye Hospital Hannover Medical School, Hannover, Germany.

Herbert Jägle (H)

Department of Ophthalmology, University Hospital, University Regensburg, Regensburg, Germany.

Smaragda Kamakari (S)

Ophthalmic Genetics Unit, OMMA Ophthalmological Institute of Athens, Athens, Greece.

Marianthi Karali (M)

Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples and Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.

Ulrich Kellner (U)

Rare Retinal Disease Center, AugenZentrum Siegburg, MVZ ADTC Siegburg GmbH, Siegburg, Germany.
RetinaScience, Bonn, Germany.

Caroline C W Klaver (CCW)

Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Ophthalmology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Bohdan Kousal (B)

Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Tina M Lamey (TM)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, WA, Australia.
Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Ian M MacDonald (IM)

Departments of Ophthalmology and Medical Genetics, University of Alberta, Edmonton, AB, Canada.

Anna Matynia (A)

Department of Ophthalmology, David Geffen School of Medicine, Stein Eye Institute, University of California-Los Angeles, Los Angeles, CA, USA.
Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.

Terri L McLaren (TL)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, WA, Australia.
Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Marcela D Mena (MD)

Laboratory of Molecular and Cellular Therapy, Fundacion Instituto Leloir-CONICET, Buenos Aires, Argentina.

Isabelle Meunier (I)

Institut des Neurosciences de Montpellier, INSERM, Université de Montpellier, Montpellier, France.

Rianne Miller (R)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Hadas Newman (H)

Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Buhle Ntozini (B)

University of Cape Town/MRC Genomic and Precision Medicine Research Unit, Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Monika Oldak (M)

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.

Marc Pieterse (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Osvaldo L Podhajcer (OL)

Laboratory of Molecular and Cellular Therapy, Fundacion Instituto Leloir-CONICET, Buenos Aires, Argentina.

Bernard Puech (B)

Service d'exploration de la vision et neuro-ophtalmologie, Centre Hospitalier Universitaire de Lille, Lille, France.

Raj Ramesar (R)

University of Cape Town/MRC Genomic and Precision Medicine Research Unit, Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Klaus Rüther (K)

Augenarztpraxis, Dorotheenstraße, Berlin, Germany.

Manar Salameh (M)

St John of Jerusalem Eye Hospital Group, East Jerusalem, Palestine.

Mariana Vallim Salles (MV)

Department of Ophthalmology and Visual Sciences, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Instituto de Genética Ocular, São Paulo, SP, Brazil.

Dror Sharon (D)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Francesca Simonelli (F)

Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.

Georg Spital (G)

Department of Ophthalmology, St. Franziskus-Hospital, Münster, Germany.

Marloes Steehouwer (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Jacek P Szaflik (JP)

Department of Ophthalmology, Medical University of Warsaw SPKSO Ophthalmic University Hospital, Warsaw, Poland.

Jennifer A Thompson (JA)

Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Caroline Thuillier (C)

CHU Lille, Institut de Génétique Médicale, Lille, France.

Anna M Tracewska (AM)

DNA Analysis Unit, ŁUKASIEWICZ Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland.

Martine van Zweeden (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Andrea L Vincent (AL)

Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, The University of Auckland, Grafton, Auckland, New Zealand.
Eye Department, Greenlane Clinical Centre, Auckland District Health Board, Auckland, New Zealand.

Xavier Zanlonghi (X)

Centre de Compétence Maladie Rare, Clinique Jules Verne, Nantes, France.

Petra Liskova (P)

Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Heidi Stöhr (H)

Institute of Human Genetics, University of Regensburg, Regensburg, Germany.

John N De Roach (JN)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, WA, Australia.
Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Carmen Ayuso (C)

Department of Genetics, IIS-Fundación Jiménez Díaz, CIBERER, Madrid, Spain.

Lisa Roberts (L)

University of Cape Town/MRC Genomic and Precision Medicine Research Unit, Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Bernhard H F Weber (BHF)

Institute of Human Genetics, University of Regensburg, Regensburg, Germany.

Claire-Marie Dhaenens (CM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Frans P M Cremers (FPM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. frans.cremers@radboudumc.nl.
Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. frans.cremers@radboudumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH